Navigation Links
Sheffield Bio-Science and Wockhardt Announce Worldwide Exclusive Partnership to Supply Recombinant Insulin to Cell Culture Market
Date:2/21/2011

BELOIT, Wis., Feb. 21, 2011 /PRNewswire/ -- Sheffield Bio-Science, a Kerry Group Business, has formed a strategic global sales, marketing and development alliance with Wockhardt Ltd. Under this partnership, Sheffield Bio-Science will be the Exclusive Global Sales and Distribution Partner for recombinant insulin manufactured by global Indian biotech Wockhardt. According to estimates, the potential in cell culture markets is around US$ 50 million.

Speaking on this landmark alliance, Dr. Habil Khorakiwala, Chairman, Wockhardt Group stated, "This partnership is a reaffirmation of Wockhardt's biotechnology research prowess and a confluence of innovative novel technology now being offered to global cell culture markets."

Sheffield's Director of Global Business Development, Hans Huttinga, stated, "We are looking forward to developing a strong and lasting partnership between our organizations."

Wockhardt was the first in Asia and only the fourth company in the world to have developed, manufactured and marketed Wosulin – recombinant insulin injectables. Wockhardt's state-of-the-art Biotech Park in Aurangabad has six dedicated manufacturing facilities and was inaugurated by the then President of India, His Excellency, Dr. APJ Abdul Kalam.

"This strategic alliance marks another step in our continued investment to strengthen our cell culture media supplement portfolio," said Edmond Scanlon, President of Sheffield Bio-Science.

Sheffield Bio-Science continues its evolution to deliver a complete novel technology platform to the global cell culture market. Customers will now have greater access to the industry's most innovative and extensive cell culture media ingredient-technologies, including recombinant proteins, chemically defined metabolic enhancers, hydrolyzed proteins, and yeast extracts. Such high quality solutions make it easier for biopharmaceutical manufacturers to delay apoptosis and maximize product yields.

About Sheffield Bio-Science:

Sheffield Bio-Science, part of Kerry Group, is a leader in innovation and applications of cell nutrition and excipients. With products ranging from media ingredients used in biotechnological production systems, to lactose, coatings and tabletting systems, Sheffield Bio-Science applies its applications expertise to deliver integrated solutions that meet unique customer challenges.

About Wockhardt:

Wockhardt is a high technology global pharmaceuticals and biotechnology major with innovative multi-disciplinary research and development programmes. It has 5 research centres and 21 world-class manufacturing plants in India, USA, UK, France and Ireland. Wockhardt has a multi-ethnic workforce of over 6500 from 14 different nationalities.


'/>"/>
SOURCE Sheffield Bio-Science, a Kerry Group Business
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sheffield Bio-Science Wins 2010 Lilly Global Supplier Award
2. Upsher-Smith Laboratories Announces Expansion of Voluntary Nationwide Recall
3. TLC Vision Announces TLC Laser Eye Center San Diego
4. American Scientific Resources Announces New Distributor HospiServices Placing Kidz-Med VeraTemp in Middle Eastern and African Pharmacies
5. Zimmer Announces Early Clinical Success of Zimmer® MotionLoc™ Screw Implantation
6. Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe
7. BioMarin Announces Fourth Quarter and Full Year 2010 Financial Results
8. Nektar to Announce Financial Results for the Fourth Quarter and Year-End of 2010 on Tuesday, March 1, 2011, After Close of U.S.-Based Financial Markets
9. Radiologic Associates of Fredericksburg Announces Image Gently Campaign to Child Size Doses for Children
10. ICAP Ocean Tomo Announces Advanced Techniques for Measuring Blood Pressure From Coherence L.L.C.
11. Symmetry Medical Announces Preliminary Unaudited Full Year 2010 Revenue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... Phoenix Marketing Solutions ( Phoenix ) ... mission of transforming science into clinical practice. During a time ... innovative approach supports the life sciences industry by ... in science and medicine — which ultimately improves lives. ... 2002 by Tracy Doyle and Angela Fiordilino ...
(Date:4/20/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical ... and Gynecology markets with innovative and proprietary products, ... Company as Senior Vice President, Marketing & Business ... will report directly to Darin Hammers , ... delighted that Ash has joined the Cogentix team," ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 Research ... Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and ... to their offering. ... market for drug delivery technologies will rise from USD 20 Billion ... Global Drug Delivery Technologies - Innovation Driven by Rapidly ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 28, 2017 , ... Somnoware, a leading provider of digital ... enables sleep physicians to create and edit their interpretation reports. This solution greatly ... familiar interface that does not require additional training to use. It also allows ...
(Date:4/28/2017)... ... April 28, 2017 , ... Getting enough sleep affects much more than energy – it also ... hours without sleep can compromise motor reaction time, which can increase the risk of having ... sharing the following tips from the NSF to help you sleep better and feel better:, ...
(Date:4/28/2017)... ... 2017 , ... Ushio America proudly introduces the new ... solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ballasts so ... lamps utilize the existing electronic ballast, saving labor and maintenance costs. It’s easy ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... been previously exposed to more adverse experiences than children in the general population. ... such as abuse, neglect or other family challenges. While no fault of their ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and ... drug safety and minimize the cost of development. In this webinar, sponsored by ... cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , ...
Breaking Medicine News(10 mins):